Research   Academics & Research   VA-MD Vet Med Home

Translational Research & Medicine

Translational medicine focuses on turning biomedical discoveries into clinical solutions for both animals and people. It is part of the growing One Health initiative—an approach dedicated to improving the lives of all species through the integration of human medicine, veterinary medicine, and environmental science.

Examples of Translational Research & Medicine

  • Dr. X. J. Meng, University Distinguished Professor of Molecular Virology, studies the molecular mechanisms of viral replication and pathogenesis and develops vaccines against emerging, reemerging, and zoonotic viral diseases, such as hepatitis E virus, porcine circovirus type 2, and porcine reproductive and respiratory syndrome virus. Learn more
  • Dr. John Rossmeisl, associate professor of neurology and neurosurgery, develops new therapeutic techniques to treat high-grade gliomas and other forms of brain cancer. He conducted a clinical trial on the use of electrical fields to deliver cancer-fighting medication past the blood-brain barrier and is now overseeing another clinical trial on the use of a type of targeted chemotherapy. Learn more.
  • Dr. Jennifer Barrett, the Theodora Ayer Randolph Professor of Equine Surgery, uses a variety of treatments, such as stem cells and platelet-rich plasma, for lameness problems in both horses and dogs. Learn more
  • Dr. Thomas Inzana, the Tyler J. and Francis F. Young Professor of Bacteriology, has developed vaccines for swine pleuropneumonia and is working on one for tularemia, an organism deemed a likely bioterrorism agent by the Centers for Disease Control (CDC) in Atlanta.
  • Former Dean Gerhardt Schurig developed the RB-51 vaccine which helped eradicate brucellosis, a disease that affects animals and people, in the United States and is still in use today. Schurig and colleagues are conducting ongoing research on the brucellosis vaccine.